Cocrystal pharma to participate in the virtual 33rd annual roth conference

Bothell, wash., march 09, 2021 (globe newswire) -- cocrystal pharma, inc.  (nasdaq: cocp), (“cocrystal” or the “company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the sars-cov-2 virus, hepatitis c viruses and noroviruses, announces that management will hold one-on-one investor meetings at the virtual 33rd annual roth conference being held march 15-17, 2021. a webcast of cocrystal's presentation has been pre-recorded and is available on the company's website here .
COCP Ratings Summary
COCP Quant Ranking